Metabolic aspects of continuous renal replacement therapies  by Druml, Wilfred
Kidney International, Vol. 56, Suppl. 72 (1999), pp. S-56–S-61
CRRT IN THE CRITICALLY ILL
Metabolic aspects of continuous renal replacement therapies
WILFRED DRUML
Department of Medicine III, Division of Nephrology, Vienna General Hospital, Vienna, Austria
Metabolic aspects of continuous renal replacement therapies. ing hemodialysis therapy, have been regarded as detri-
Continuous renal replacement therapies (CRRTs) are associ- mental to the patient’s health.
ated with a broad pattern of additional metabolic effects be- Continuous renal replacement therapies (CRRTs)yond renal detoxification. Because of the continuous mode of
have become the first line of renal replacement therapytherapy and the high fluid turnover usually associated with
in critically ill patients with acute renal failure. Also,CRRTs, these side effects can become clinically relevant. With
many CRRT systems currently used, heat loss is considerable, CRRTs are associated with a broad spectrum of meta-
but CRRTs can also be used to modulate body temperature bolic side effects that become clinically relevant because
in hyperpyrectic patients. Inappropriate glucose concentrations of the continuous mode of therapy lasting several daysof some substitution fluids can result in excessive glucose in-
or even weeks, and the high turnover of fluids usedtake. Most substitution and/or dialysate fluids used for CRRTs
as the fluid replacement or dialysate. Not all of thesecontain lactate as organic anion. In disease states with impaired
lactate utilization, such as acute or chronic liver failure, and/ additional effects are necessarily undesirable, as several
or with increased endogenous lactate formation such as in metabolic consequences of CRRTs can be beneficial in
shock states, this can result in hyperlactemia and is potentially certain clinical conditions [1, 2]. Knowledge of theseassociated with various adverse side effects. Small molecular
additional metabolic effects is mandatory for designingweight substances such as amino acids or water-soluble vitamins
an optimal nutritional regimen for patients treated withare lost in relevant amounts. With convective clearance and
the high molecular cut-off of synthetic membranes, medium- CRRTs [3].
sized molecules such as hormones and cytokines are also filtered,
but the pathophysiologic relevance of this observation remains
to be specified. Moreover, synthetic membranes used for CRRTs HEAT LOSS
have adsorptive properties for a variety of molecules, such
Continuous hemofiltration will induce a considerableas cytokines, complement factors, and endotoxin. Continuous
heat loss—as in many instances—during the use of CRRTblood membrane interactions cause the phenomena of bioin-
compatibility and a low-grade inflammatory reaction with po- systems without warming equipment for blood or for
tentially adverse consequences on protein metabolism and im- substitution fluid. Even newer systems that heat only
munocompetence. In designing a nutritional program for a the substitution fluid result in a negative temperaturepatient on CRRT, these metabolic effects—especially the loss
balance for the patient. Depending on the extent of fluidof nutritional substrates—must be considered. Certainly, most
turnover, this caloric loss can account for as much asof these side effects, such as the excessive load of lactate or
the loss of nutrients, are undesirable. However, some side ef- 1500 kcal/day and will usually result in a fall in body
fects, such as the modulation of body temperature and the temperature [4, 5].
elimination of endotoxin and/or mediators, might be at least
In several clinical conditions, treatment-induced hypo-potentially beneficial.
thermia can be a desired effect, for example, in hyperpyr-
ectic states and in multiple organ failure associated with
cardiovascular instability. A reduction of body tempera-Obviously, the primary intention to initiate renal re-
ture in these conditions can reduce oxygen consumption,placement is to reverse the metabolic consequences in-
improve cardiovascular stability, and may also mitigateduced by renal shutdown. Nevertheless, besides this pre-
the extent of protein catabolism.dominant metabolic function, various renal replacement
Thus, CRRTs can contribute to a reduction of oxygentherapies are associated with many other metabolic side
consumption in clinical states associated with hypermeta-effects. Usually most of these additional effects, such as
bolism, and may help optimize the relationship betweenloss of nutrients or induction of protein catabolism dur-
oxygen consumption (fall in VO2 by the reduction of
body temperature) and oxygen delivery (DO2) [5]. How-
ever, if intravascular volume is depleted by vigorousKey words: CRRT, metabolism, nutrition, hyperlactemia, dialysis
membrane. dehydration [as has been advocated in the treatment of
acute respiratory distress syndrome (ARDS)], continu- 1999 by the International Society of Nephrology
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ous hemofiltration will result in a fall in DO2 and may contain glucose in a concentration of 100 to 180 mg/dl
in order to maintain a zero glucose balance.actually may deteriorate the VO2/DO2 relationship.
A decrease in temperature of returning venous blood
has been identified as an important factor for hemody-
LACTATE, ACETATE, OR CITRATE INTAKE
namic stability during renal replacement therapy. Recent
Most available substitution solutions for CRRTs con-studies have clearly demonstrated that extracorporeal
tain lactate as an organic anion. Unfortunately, DL-lac-blood temperature is the main determinant of blood
tate is still in use in several countries. This should bepressure response during hemofiltration and hemodialy-
replaced by pure L-lactate because of the potential toxicsis [6, 7].
side-effects induced by the unphysiologic D-lactate.Potentially, the therapy-associated heat loss may also
Depending on the filtered volume/day and the amountgenerate untoward effects by blunting the metabolic re-
of fluid replacement, the organism is exposed to a poten-sponse to infection and/or injury. Fever certainly is a
tially relevant if not excessive amount of lactate. This mayphysiological phenomenon that is relevant for the con-
amount to as much as 2000 mmol/day and can equal thetrol of infection and expression of heat shock proteins.
endogenous lactate turnover rate during physiologicalTherapy-induced hypothermia might thus impair immu-
conditions (about 2400 mmol/24 hr in healthy subjects).nocompetence of the organism.
This lactate load gains clinical relevance in diseaseSeveral modern hemofiltration machines include a
states in which either endogenous lactate utilization isheating system by which the blood line or the substitution
impaired (such as in acute or chronic liver failure) or influid can be warmed as desired.
clinical conditions associated with an increased lactateCaloric loss during CRRTs should be considered when
formation because of an impairment of microvascularcalculating the energy balance of a patient, and must
perfusion, such as in circulatory shock, septic shock, orbe compensated for by increasing the intake of energy
hypoxic states. Under these conditions, any renal re-substrates such as glucose or fat emulsions during nutri-
placement therapy using lactate-containing solutions willtional therapy. On the other hand, hemofiltration fluids
increase plasma lactate concentrations.contain lactate, which are anions that when oxidated can
Recent evidence suggests that hyperlactemia inducedpartially substitute for the heat loss.
by exogenous lactate infusion may present more than
just a deranged laboratory value; it can assume patho-
GLUCOSE BALANCE physiological relevance. Several adverse consequences
such as an impairment of myocardial contractility, inhibi-Glucose balance during CRRT is obviously dependent
on the glucose concentration of the substitution fluid. tion of endogenous lactate metabolism, and aggravation
of insulin resistance have been reported [9–11]. Further-The use of glucose-free solutions does not contribute to
an improvement—as has been falsely assumed—in the more, it was suggested that lactate-containing substitu-
tion fluids may promote protein catabolism. Moreover,metabolic control in patients with impaired glucose utili-
zation, for example, in most patients with acute disease with the impairment of interconversion of lactate to bi-
carbonate, the control of acid-base balance is blunted.states. This plainly results in a glucose loss accounting
for 40 to 80 g/day depending on the filtration volume, The clinically acceptable extent of blood lactate level
elevation during therapy remains to be defined, but iswhich must be compensated for by an activation of en-
dogenous gluconeogenesis mainly from amino acids, thus usually regarded to be within the range of 3 to 4 mmol/
liter.promoting protein breakdown. Glucose loss during the
use of glucose-free solutions must be considered when Lactate, acetate, and citrate are energy-yielding sub-
strates that are metabolized in the tricarbonic acid cycleevaluating the energy balance of the patient, and it must
be replaced by nutritional therapy. and generate bicarbonate. Little is known on the impact
of these compounds on energy metabolism in the criti-In contrast, in several institutions, solutions designed
for peritoneal dialysis have been used for CRRT. These cally ill patient. Lactate is used as an energy substrate by
several tissues, including the myocardium, and in sharpsolutions have extreme glucose concentrations of 1240
to 3600 mg/dl, and should no longer be used because of contrast to the potential side effects of excessive lactate
intake mentioned earlier in this article, there is also evi-the associated excessive glucose uptake [8]. Nutritional
therapy should be separated from renal replacement ther- dence that lactate might support myocardial functions
[12]. Nevertheless, the lactate load may correspond toapy. It should be kept in mind that with modern nutri-
tional support, recommendations for glucose intake have an caloric intake of up to 500 kcal, which should be
considered in calculating the energy balance of patients.been reduced during recent years and should be re-
stricted to a maximal amount of 5 g of glucose/kg body In all clinical conditions associated either with an in-
creased endogenous lactate production (such as in circu-wt/day.
Thus, the substitution fluids used in CRRTs should latory shock) or an impaired lactate utilization (espe-
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cially in patients with liver failure), acetate- and lactate- tional to the filtered volume and the plasma concentra-
containing substitution fluids should be replaced by bi- tion of the substrate, and can thus be easily estimated
carbonate-buffered substitution fluids, which have be- from the average plasma concentration and the fluid
come available in several countries. turnover. During continuous hemodialysis and/or hemo-
Acetate-containing solutions are restricted to special dialfiltration, which have become increasingly popular
indications, such as patients with hyperlactemia and asso- during the recent years, this loss of low molecular weight
ciated metabolic alkalosis. The infusion of large amounts substances is even augmented by diffusive transport.
of acetate during CRRT is associated with well-docu-
mented side effects in intensive care patients, such as Amino acids
systemic vasodilation and reduction of myocardial con- Because of their small molecular size (mean molecular
tractility, and it may also aggravate cardiovascular insta- weight 145 Daltons), the sieving coefficient of amino
bility. acids approximates 1.0; thus, CRRT will result in the
Regional citrate anticoagulation is increasingly used elimination of amino acids from the bloodstream. During
during CRRTs [13–15]. During this type of anticoagula- postdilutional hemofiltration this loss accounts for ap-
tion, bicarbonate and/or lactate concentrations must be proximately 0.25 g amino acids/liter filtered volume. Dif-
reduced to avoid inducing metabolic alkalosis associated fusive clearance of amino acids during continuous hemo-
with excessive organic anion infusion. Little is known
dialysis increases these losses. Depending on filtrate
about citrate utilization in the critically ill. However, in
volume per day and/or dialysate flow, amino acid losspatients on chronic hemodialysis therapy with minimal
will account for 6 to 15 g amino acids/day during CRRTresidual renal function, lactate elimination is not grossly
[19–21].retarded (abstract; Apsner et al, Wien Klin Wochschr
Because the actual amount of an amino acid lost dur-110(Suppl 4):3A, 1998).
ing CRRT is dependent on the plasma concentration,
amino acids with high plasma levels are eliminated at a
ELECTROLYTE DERANGEMENTS higher rate. The elimination of glutamine, the amino
acid with the highest plasma concentration of all aminoMost available substitution fluids used in CRRTs have
acids, is also most pronounced during CRRT [22]. How-originally been designed for intermittent hemofiltration
ever, this also has a therapeutic aspect, because duringin chronic renal failure patients. The use of these solu-
CRRT, derangements of the plasma amino acid profiletions can induce pronounced electrolyte derangements in
patients with acute renal failure. The inadequate sodium can be avoided, and imbalances of amino acid concentra-
concentration for replacement of large quantities of tions are smoothed.
plasma water (with a higher sodium concentration) will In patients with acute renal failure treated by CRRTs,
result in a negative sodium balance and hyponatremia nutritional solutions obviously must be given during ex-
in a considerable fraction of patients. tracorporeal therapy. The endogenous clearance of
Most solutions do not contain phosphate and can ag- amino acids is in the range of 80 to 1800 ml/min and
gravate hypophosphatemia, which can frequently de- thus exceeds dialytic clearance 10 to 100 times, so infu-
velop in patients with acute renal failure. The concomi- sion results in minimal increases in plasma amino acid
tant use of phosphate-free parenteral nutrition increases concentrations [3, 23]. Consequently, a small fraction of
the risk of phosphate depletion [16–18]. only the infused amino acids will be removed in addition
Similarly, because many of these substitution fluids to the basal amino acid elimination, and the nutritional
are free of magnesium, a negative magnesium balance solution infused during hemodialysis/CRRT does not
is induced by CRRT. Hypomagnesemia can also evolve substantially augment amino acid losses. Only about 10
when citrate is used as an anticoagulant that not only to 15% of the amino acids given are lost in the dialysate/
complexes with calcium but also with magnesium. hemofiltrate [19, 20, 23]. During clinically relevant infu-
During use of citrate anticoagulation, profound hypo-
sion rates, amino acid loss is not correlated to amino
calcemia can occur with insufficient calcium supplemen-
acid intake. However, any exaggerated intake of aminotation.
acids (some authors administer up to 2.5 g amino acids/
kg/day) must also increase the therapy-induced amino
LOSS OF NUTRIENTS acid elimination [21].
When designing a nutritional program, this obligatoryWater soluble molecules with a low molecular size
loss of substrates must be considered in estimation ofand low protein binding, such as amino acids or water
nitrogen requirements. Amino acid supply should besoluble vitamins, are eliminated during CRRT, resulting
raised by approximately 0.2 g/kg/day to compensate forin a considerable loss of several nutritional substrates.
During postdilutional hemofiltration, this loss is propor- these therapy-associated losses [3].
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Micronutrients of mediators is achieved by CRRT [31]. Obviously, the
convective clearance does not only extend to “bad mole-It is well documented that water soluble vitamins are
cules” (mediators), which are implicated in the evolutioneliminated by conventional hemodialysis [24]. For CRRT,
of the systemic inflammatory response syndrome andfew balanced studies are available. Relevant amounts of
multiple organ dysfunction syndrome, but also to othervitamin C are lost during continuous hemofiltration [25].
immunomodulatory substances. Potentially, the subtleIn a patient on CRRT, vitamin B1 (thiamine) depletion
balance between pro-inflammatory and anti-inflamma-was induced during CRRT, resulting in lactic acidosis
tory factors can be affected during CRRT. There is evi-and right ventricular dysfunction of the heart [26]. The
dence that CRRTs attenuate the up-regulation of phago-loss of nutritional antioxidants during CRRT can con-
cytosis of polymorphonuclear leukocytes and can impairtribute to the profound impairment of the oxygen radical
the host response to infection [32].scavenger system present in critically ill patients (ab-
An example of the potential elimination of “benefi-stract; Druml et al, J Am Soc Nephrol 4:314A, 1993).
cial” molecules during CRRT is hormones. For catechol-Fat soluble vitamins are bound to transport proteins
amines the extracorporeal extraction rate is high, butand/or transported by plasma lipoproteins. Thus, the low
concentrations observed in patients with acute renal fail- nevertheless, this does not affect plasma concentration
ure are not caused by elimination during CRRT [27]. and the need for exogenous catecholamine infusion, and
Also, a loss of trace elements is negligible during does not impair cardiovascular stability [33]. Similarly,
CRRT because of the high protein binding [28]. De- insulin has excellent filtration properties, but this fact
creased plasma concentrations of some trace elements, obviously does not aggravate glucose intolerance, in-
especially selenium, seen in patients with acute renal crease insulin requirements, or even induce a diabetic
failure again are not induced by extracorporeal elimina- state during treatment. Again, the amount eliminated in
tion, but rather by an internal redistribution between the extracorporeal circuit is so small in relationship to
various tissues. Because many substitution fluids contain whole body turnover that the fraction lost is not relevant.
undefined and variable amounts of various trace ele- Because the molecular cut-off curve of modern mem-
ments, it is difficult to assess trace element balances in branes for CRRT is not very steep, proteins of a higher
patients on CRRT. molecular weight are to some extent eliminated. Protein
losses, however, are moderately higher during convec-
tion-based CRRT (60 mg/liter) than during diffusion-ELIMINATION OF PEPTIDES AND
based CRRT (27 mg/liter), and can vary between 1.2SHORT-CHAIN PROTEINS
and 7.5 g/day [34].The convective transport of continuous hemofiltration
or hemodiafiltration is characterized by a near linear
clearance of molecules up to a molecular weight defined ADSORPTIVE PROPERTIES OF
by the pore size of the filtration membrane. The “cut- ARTIFICIAL MEMBRANES
off” of the commonly used filtration membranes ranges
Elimination of substances during CRRT is not onlybetween 20 and 40 kDa, and thus, small proteins, such
mediated by convection and/or diffusion, but also byas peptide hormones (insulin, catecholamines) but po-
the adsorption of proteins (hormones, interleukins, andtentially also mediators and cytokines, are filtered.
other potential mediators) and possibly also of endotox-In fact, many peptides can be detected in the filtrate
ins to the membrane. The adsorptive properties are de-[29]. To discuss the pathophysiological relevance of the
termined by the membrane material used. Adsorptionelimination of a substance by hemofiltration, two points
of complement factor D is most pronounced with mem-must be considered: (a) the magnitude of the circulating
branes composed of polyacrylonitrile. Endotoxin ad-pool as a fraction of total pool of a putative molecule,
sorption is highest with polyamide [35, 36]. Again, theand (b) the amount eliminated in relation to the half-
clinical relevance of these properties of synthetic mem-life and whole body turnover. Even if a compound is
branes remains to be specified.filtered with a sieving coefficient of 1.0, the eliminated
When assessing the potential clinical relevance ofamount is negligible when the endogenous turnover rate
these mechanisms, it must be considered that the adsorp-is high, which exists for all mediators and hormones.
tive effect is for a limited duration. After saturation ofPotential elimination of putative “mediators” involved
the membrane, adsorption sharply decreases, and thus,in the development and/or maintenance of sepsis and/or
certainly after four to eight hours of treatment no furthermultiple organ dysfunction syndrome (MODS), such as
adsorptive effectivity can be expected. If an adsorptivetumor necrosis factor-a or interleukins, has recently been
property of the membrane is a therapeutically desiredanalyzed in several reviews and beyond the scope of this
effect, this suggests that the filters must be regularlyarticle [29, 30]. Currently, there is no evidence from
clinical studies that a quantitatively relevant elimination replaced (maximal filter time 8 to 12 hr).
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